Sadhna Verma, MD, FSAR, presented “PIRADS V2.1 – What a Urologist Needs to Know? ” during the 2024 Frontiers in Oncologic Prostate Care and Ablative Local Therapy symposium on October 17, 2024, in San Diego, California.
>
How to cite: Verma, Sadhna. “PIRADS V2.1 – What a Urologist Needs to Know?.” October, 2024. Accessed Jan 2025. https://grandroundsinurology.com/pirads-v2-1-what-a-urologist-needs-to-know/
PIRADS V2.1 – What a Urologist Needs to Know? – Summary
Sadhna Verma, MD, MBA, FSAR, begins this 20-minute presentation by emphasizing the exponential growth of prostate MRI usage and its critical role in prostate cancer detection. Before diving into PI-RADS, the multiparametric MRI approach is explained. T2-weighted sequences are highlighted as the best for anatomical visualization.
PI-RADS scoring, a standardized Likert-like system ranging from 1 to 5, assesses the likelihood of malignancy of a lesion based on size, location, and imaging characteristics. PI-RADS version 2.1 introduces refinements, particularly for transition zone lesions. The updated guidelines also incorporate templates to standardize reporting and emphasize quality assurance. Central zone tumors are recognized for their aggressive nature and specific imaging features.
Dr.Verma shares images to illustrate the scoring refinements of PI-RADS version 2.1. Despite advancements, quality variability in imaging and interpretation remains a concern. Collaborative initiatives led by the American College of Radiology aim to enhance diagnostic accuracy. Dr. Verma emphasizes the need for ongoing quality assurance and training to address current limitations and improve clinical outcomes.
Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) is an outstanding program on prostate imaging, transperineal interventions, and ablative treatments for prostate cancer and benign prostatic hyperplasia. Bringing together community-based, academic, and industry partners, FOCAL offers lectures by world-renowned faculty and hands-on training workshops on in-office transperineal interventions, fusion-guided prostate ablation and state-of-the-art BPH management with novel technologies.
ABOUT THE AUTHOR
Sadhna Verma, MD, FSAR, is a Professor of Radiology, Radiation Oncology and Urology at University of Cincinnati Medical Center. She is also the Director of Prostate Imaging Program, Associate Chair of Quality and Performance Improvement at the Prostate Cancer Midwest Center of Excellence, as well as the Director Prostate Cancer Imaging Program at the U.S. Department of Veterans Affairs.
Dr. Verma completed a diagnostic radiology residency at the University of Cincinnati and a fellowship in Abdominal Imaging from the Johns Hopkins Medical Center. Dr. Verma’s clinical expertise and current clinical research interests are in genitourinary MR imaging. She has published extensively and delivered numerous invited lectures on the topic of prostate MRI and MR-Guided Interventional Procedures.
